Abstract: The compounds are substituted pyrimidine compounds which are histamine H.sub.2 -antagonists. A specific compound of the present invention is 2-[2-(5-dimethylaminomethyl)-2-furylmethylthio)ethylamino]-5-(3-pyridylmet hyl)-4-pyrimidone.
Type:
Grant
Filed:
June 21, 1985
Date of Patent:
March 10, 1987
Assignee:
Smith Kline & French Laboratories Limited